Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 24 studies | 33% ± 16% | |
| endothelial cell of lymphatic vessel | 20 studies | 50% ± 19% | |
| pericyte | 14 studies | 42% ± 23% | |
| smooth muscle cell | 13 studies | 36% ± 15% | |
| vein endothelial cell | 10 studies | 33% ± 5% | |
| endothelial cell of vascular tree | 8 studies | 36% ± 9% | |
| retinal ganglion cell | 7 studies | 75% ± 28% | |
| capillary endothelial cell | 6 studies | 20% ± 3% | |
| epithelial cell | 6 studies | 48% ± 34% | |
| endothelial cell of artery | 5 studies | 20% ± 2% | |
| neuron | 4 studies | 38% ± 19% | |
| retina horizontal cell | 4 studies | 39% ± 21% | |
| basal cell | 4 studies | 28% ± 13% | |
| secretory cell | 4 studies | 27% ± 3% | |
| OFF-bipolar cell | 3 studies | 71% ± 22% | |
| ON-bipolar cell | 3 studies | 66% ± 25% | |
| abnormal cell | 3 studies | 24% ± 7% | |
| GABAergic neuron | 3 studies | 34% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 5 studies | 34% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 9431.72 | 258 / 258 | 72% | 312.98 | 165 / 230 |
| bladder | 100% | 6679.90 | 21 / 21 | 66% | 616.74 | 335 / 504 |
| ovary | 76% | 1434.18 | 136 / 180 | 88% | 233.69 | 377 / 430 |
| brain | 97% | 6743.40 | 2564 / 2642 | 59% | 56.60 | 419 / 705 |
| breast | 98% | 3843.22 | 451 / 459 | 57% | 60.48 | 640 / 1118 |
| prostate | 80% | 1375.71 | 196 / 245 | 53% | 25.55 | 266 / 502 |
| uterus | 75% | 1236.01 | 127 / 170 | 56% | 130.90 | 255 / 459 |
| thymus | 56% | 683.85 | 368 / 653 | 69% | 51.28 | 420 / 605 |
| ureter | 0% | 0 | 0 / 0 | 100% | 58.46 | 1 / 1 |
| adipose | 99% | 5158.02 | 1195 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 99% | 2465.00 | 238 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 6379.45 | 1302 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 31% | 371.45 | 28 / 89 | 64% | 60.49 | 581 / 901 |
| esophagus | 63% | 918.12 | 912 / 1445 | 19% | 8.97 | 35 / 183 |
| lung | 31% | 326.45 | 181 / 578 | 41% | 52.33 | 475 / 1155 |
| pancreas | 0% | 0 | 0 / 328 | 67% | 109.13 | 119 / 178 |
| skin | 52% | 638.76 | 947 / 1809 | 12% | 7.27 | 56 / 472 |
| intestine | 49% | 685.16 | 475 / 966 | 9% | 5.08 | 46 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 36.86 | 22 / 45 |
| stomach | 26% | 358.80 | 93 / 359 | 9% | 3.70 | 25 / 286 |
| heart | 30% | 287.36 | 256 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 14.93 | 1 / 226 | 29% | 51.50 | 117 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 3.30 | 3 / 29 |
| muscle | 5% | 67.34 | 44 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 6.71 | 3 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008344 | Biological process | adult locomotory behavior |
| GO_0048488 | Biological process | synaptic vesicle endocytosis |
| GO_0014059 | Biological process | regulation of dopamine secretion |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_0050808 | Biological process | synapse organization |
| GO_0046928 | Biological process | regulation of neurotransmitter secretion |
| GO_0009306 | Biological process | protein secretion |
| GO_0005813 | Cellular component | centrosome |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0043679 | Cellular component | axon terminus |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0005819 | Cellular component | spindle |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_1903136 | Molecular function | cuprous ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SNCG |
| Protein name | Synuclein gamma Gamma-synuclein Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin) (SR) |
| Synonyms | BCSG1 PRSN PERSYN hCG_23263 |
| Description | FUNCTION: Plays a role in neurofilament network integrity. May be involved in modulating axonal architecture during development and in the adult. In vitro, increases the susceptibility of neurofilament-H to calcium-dependent proteases (By similarity). May also function in modulating the keratin network in skin. Activates the MAPK and Elk-1 signal transduction pathway (By similarity). . |
| Accessions | ENST00000372017.4 A9XXE1 ENST00000348795.8 F8W754 Q6FHG5 O76070 |